Biotech innovation in obesity care spotlights a different therapeutic angle. Read an optimistic look at implications for metabolic health.
Key Takeaways
- Preclinical data showed the mitochondrial small molecule reduced ectopic fat and improved metabolic markers
- Treatment preserved lean mass and produced improvements in muscle strength in treated animals
- Combining the compound with tirzepatide yielded a reported 50.64% body weight reduction in the study